Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q3 2023 · 10-Q
Revenue$294.15M$294.15M+1.3% vs Q3 2022 Net Income$70.22M$70.22M+15.6% vs Q3 2022 EPS Diluted$0.43$0.43+16.2% vs Q3 2022 Gross Profit$202,162,000+0.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$50,535,000−30.9% Free Cash Flowderived$38,787,000−33.2% Margins · derivedGross margin68.7%−0.6 pt vs Q3 2022
Operating margin27.3%−3.9 pt vs Q3 2022
Net margin23.9%+3.0 pt vs Q3 2022
ended Mar 31, 2023 · filed May 8, 2023 · 38 d after period end